These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38308631)

  • 1. Discovery of Orally Bioavailable FmlH Lectin Antagonists as Treatment for Urinary Tract Infections.
    Maddirala AR; Tamadonfar K; Pinkner JS; Sanick D; Hultgren SJ; Janetka JW
    J Med Chem; 2024 Mar; 67(5):3668-3678. PubMed ID: 38308631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biphenyl Gal and GalNAc FmlH Lectin Antagonists of Uropathogenic E. coli (UPEC): Optimization through Iterative Rational Drug Design.
    Maddirala AR; Klein R; Pinkner JS; Kalas V; Hultgren SJ; Janetka JW
    J Med Chem; 2019 Jan; 62(2):467-479. PubMed ID: 30540910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based discovery of glycomimetic FmlH ligands as inhibitors of bacterial adhesion during urinary tract infection.
    Kalas V; Hibbing ME; Maddirala AR; Chugani R; Pinkner JS; Mydock-McGrane LK; Conover MS; Janetka JW; Hultgren SJ
    Proc Natl Acad Sci U S A; 2018 Mar; 115(12):E2819-E2828. PubMed ID: 29507247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying FmlH lectin-binding small molecules for the prevention of Escherichia coli-induced urinary tract infections using hybrid fragment-based design and molecular docking.
    Samanta P; Doerksen RJ
    Comput Biol Med; 2023 Sep; 163():107072. PubMed ID: 37329611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antivirulence Isoquinolone Mannosides: Optimization of the Biaryl Aglycone for FimH Lectin Binding Affinity and Efficacy in the Treatment of Chronic UTI.
    Jarvis C; Han Z; Kalas V; Klein R; Pinkner JS; Ford B; Binkley J; Cusumano CK; Cusumano Z; Mydock-McGrane L; Hultgren SJ; Janetka JW
    ChemMedChem; 2016 Feb; 11(4):367-73. PubMed ID: 26812660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation-Induced Adhesin-Receptor Interaction Provides a Fitness Advantage to Uropathogenic E. coli during Chronic Infection.
    Conover MS; Ruer S; Taganna J; Kalas V; De Greve H; Pinkner JS; Dodson KW; Remaut H; Hultgren SJ
    Cell Host Microbe; 2016 Oct; 20(4):482-492. PubMed ID: 27667696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FimH antagonists: bioisosteres to improve the in vitro and in vivo PK/PD profile.
    Kleeb S; Pang L; Mayer K; Eris D; Sigl A; Preston RC; Zihlmann P; Sharpe T; Jakob RP; Abgottspon D; Hutter AS; Scharenberg M; Jiang X; Navarra G; Rabbani S; Smiesko M; Lüdin N; Bezençon J; Schwardt O; Maier T; Ernst B
    J Med Chem; 2015 Mar; 58(5):2221-39. PubMed ID: 25666045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combinatorial small-molecule therapy prevents uropathogenic Escherichia coli catheter-associated urinary tract infections in mice.
    Guiton PS; Cusumano CK; Kline KA; Dodson KW; Han Z; Janetka JW; Henderson JP; Caparon MG; Hultgren SJ
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4738-45. PubMed ID: 22733070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral supplementation of trans-cinnamaldehyde reduces uropathogenic Escherichia coli colonization in a mouse model.
    Narayanan A; Muyyarikkandy MS; Mooyottu S; Venkitanarayanan K; Amalaradjou MA
    Lett Appl Microbiol; 2017 Mar; 64(3):192-197. PubMed ID: 28063174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. d-Mannose Treatment neither Affects Uropathogenic
    Scribano D; Sarshar M; Prezioso C; Lucarelli M; Angeloni A; Zagaglia C; Palamara AT; Ambrosi C
    Molecules; 2020 Jan; 25(2):. PubMed ID: 31941080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A flow cytometry-based assay for screening FimH antagonists.
    Scharenberg M; Abgottspon D; Cicek E; Jiang X; Schwardt O; Rabbani S; Ernst B
    Assay Drug Dev Technol; 2011 Oct; 9(5):455-64. PubMed ID: 21675870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiadhesive natural products against uropathogenic E. coli: What can we learn from cranberry extract?
    Scharf B; Schmidt TJ; Rabbani S; Stork C; Dobrindt U; Sendker J; Ernst B; Hensel A
    J Ethnopharmacol; 2020 Jul; 257():112889. PubMed ID: 32311481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational design strategies for FimH antagonists: new drugs on the horizon for urinary tract infection and Crohn's disease.
    Mydock-McGrane LK; Hannan TJ; Janetka JW
    Expert Opin Drug Discov; 2017 Jul; 12(7):711-731. PubMed ID: 28506090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CpxA Phosphatase Inhibitor Activates CpxRA and Is a Potential Treatment for Uropathogenic Escherichia coli in a Murine Model of Infection.
    Fortney KR; Smith SN; van Rensburg JJ; Brothwell JA; Gardner JJ; Katz BP; Ahsan N; Duerfeldt AS; Mobley HLT; Spinola SM
    Microbiol Spectr; 2022 Apr; 10(2):e0243021. PubMed ID: 35297652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment and prevention of urinary tract infection with orally active FimH inhibitors.
    Cusumano CK; Pinkner JS; Han Z; Greene SE; Ford BA; Crowley JR; Henderson JP; Janetka JW; Hultgren SJ
    Sci Transl Med; 2011 Nov; 3(109):109ra115. PubMed ID: 22089451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surfactant protein D inhibits adherence of uropathogenic Escherichia coli to the bladder epithelial cells and the bacterium-induced cytotoxicity: a possible function in urinary tract.
    Kurimura Y; Nishitani C; Ariki S; Saito A; Hasegawa Y; Takahashi M; Hashimoto J; Takahashi S; Tsukamoto T; Kuroki Y
    J Biol Chem; 2012 Nov; 287(47):39578-88. PubMed ID: 23012359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and biological evaluation of mannosyl triazoles as FimH antagonists.
    Schwardt O; Rabbani S; Hartmann M; Abgottspon D; Wittwer M; Kleeb S; Zalewski A; Smieško M; Cutting B; Ernst B
    Bioorg Med Chem; 2011 Nov; 19(21):6454-73. PubMed ID: 21962988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FimH antagonists for the oral treatment of urinary tract infections: from design and synthesis to in vitro and in vivo evaluation.
    Klein T; Abgottspon D; Wittwer M; Rabbani S; Herold J; Jiang X; Kleeb S; Lüthi C; Scharenberg M; Bezençon J; Gubler E; Pang L; Smiesko M; Cutting B; Schwardt O; Ernst B
    J Med Chem; 2010 Dec; 53(24):8627-41. PubMed ID: 21105658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plant phenolics inhibit focal adhesion kinase and suppress host cell invasion by uropathogenic
    Lewis AJ; Richards AC; Mendez AA; Dhakal BK; Jones TA; Sundsbak JL; Eto DS; Rousek AA; Mulvey MA
    Infect Immun; 2024 May; 92(5):e0008024. PubMed ID: 38534100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uropathogenic
    Alfuraiji N; Al-Hamami A; Ibrahim M; Rajab HK; Hussain BW
    J Med Life; 2022 May; 15(5):650-654. PubMed ID: 35815089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.